Philippines Government Slaps Price Caps On Innovative Drugs; Pfizer Reacts With Disappointment
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - After pressuring international pharmaceutical companies to drastically reduce prices on a list of basic drugs, with mixed results, the Philippines government is imposing price caps by executive order in a move that will take effect August 15